Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative esketamine analgesia and short-term sleep quality after thoracoscopy
ChiCTR2400088106Phase 4Not yet recruiting
- Sponsor
- Weihai Municipal Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in sleep disorder and postoperative pain (2 arms), sponsored by Weihai Municipal Hospital. Primary endpoint: Postoperative sleep condition. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
sleep disorderpostoperative pain
Beyond the preview
Go deeper on ChiCTR2400088106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088106.